title: [A case of advanced right colonic cancer successfully treated by surgery and post operative chemotherapy].
abstract: A 45-year-old male patient with right colonic cancer, of which clinical finding was SIM1 (No.216), Stage IV, underwent extended right hemicolectomy with paraaortic lymph node resection as surgical treatment. However, CY1 was detected and a final finding was SIM1 (No.216) H0CY1, Stage IV. After the operation, we administered 3-course of FOLFOX4 plus bevacizumab protocol, 3-course of FOLFOX4, 6-course of FOLFIRI, and 6-course of IRIS for one year. The patient is presently alive with no sign of recurrence after 22 months.
authors.affiliation: Department of Surgery, Tokyo Metropolitan Bokutoh Hospital.
authors.forename: Kazumasa
authors.initials: K
authors.lastname: Noda
authors.forename: Nobutaka
authors.initials: N
authors.lastname: Umekita
authors.forename: Keiichi
authors.initials: K
authors.lastname: Nasu
authors.forename: Satoshi
authors.initials: S
authors.lastname: Inoue
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D000068258:Bevacizumab; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D003110:Colonic Neoplasms / Q000628:therapy*; D003131:Combined Modality Therapy; D004338:Drug Combinations; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin / Q000008:administration & dosage; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010094:Oxonic Acid / Q000008:administration & dosage; D011184:Postoperative Period; D005641:Tegafur / Q000008:administration & dosage
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D004338:Drug Combinations; D009944:Organoplatinum Compounds; C079198:S 1 (combination); D005641:Tegafur; D000068258:Bevacizumab; D010094:Oxonic Acid; D000077146:Irinotecan; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin